http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 11 Mar 2026 06:20:09 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/Boston+Scientific+%28BSX%29+PT+Lowered+to+%2495+at+Baird/26142262.html Baird analyst David Rescott lowered the price target on Boston Scientific (NYSE: BSX) to $95.00 (from $101.00) while maintaining a Outperform rating. http://www.streetinsider.com/Analyst+PT+Change/Boston+Scientific+%28BSX%29+PT+Lowered+to+%2495+at+Baird/26142262.html Wed, 11 Mar 2026 06:20:09 -0400 BSX http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Press+Releases/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html <p>PHILADELPHIA, March 10, 2026 (GLOBE NEWSWIRE) -- </p> <p align="justify"><strong>Boston Scientific Corporation (NYSE: BSX)</strong><strong>:</strong></p> <p align="justify"><strong>WHAT IS HAPPENING?</strong> Grabar Law Office is investigating claims on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p> <p align="justify"><strong>If you purchased Boston Scientific (NYSE: BSX) shares prior to </strong><strong>July 23, 2025, </strong><strong>you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.</strong> <strong>You are encouraged to visit http://www.streetinsider.com/Globe+Newswire/Important+Notice+to+Long-Term+Shareholders+of+Boston+Scientific+Corporation+%28NYSE%3A+BSX%29%3A+Corcept+Therapeutics%2C+Inc.+%28NASDAQ%3A+CORT%29%3B+Nektar+Therapeutics+%28NASDAQ%3A+NKTR%29%3A+and+Unicycive+Therapeutics%2C+Inc./26136760.html Tue, 10 Mar 2026 09:08:00 -0400 A.06822034 A.50216024 BSX CORT NKTR O.00016491 O.00168666 O.00646884 O.20026344 O.48148085 O.50789672 UNCY